TrialCancer chemotherapy and pharmacology2019

A drug-drug interaction study to assess the potential effect of acid-reducing agent, lansoprazole, on quizartinib pharmacokinetics.

Jianke Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.